TrialMuscle & nerve2025

A 40-week phase 2B randomized, multicenter, double-blind, placebo-controlled study evaluating the safety and efficacy of memantine in amyotrophic lateral sclerosis.

Salman Bhai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.